Dr. Abdulla Al. Mehrezi

• Hematologist
• Oncologist

Available specialties and services can be selected before viewing the schedule.

The doctor sees patients at the following clinics:

1. Burjeel Hospital
   Abu Dhabi, Al Najdah Street PO Box: 7400 Abu Dhabi, United Arab Emirates

1. Choose the doctor or service you need at the desired branch.
2. Select an available date and time.
3. Enter your booking details and confirm your appointment.

After booking, you will receive a confirmation with the appointment details. Booking through odoctor.ae is free and does not require calling the clinic.

The appointment fee starts from AED 500. The exact price depends on the selected service and branch. It will be shown when booking, before the appointment is confirmed.

Additional tests and procedures may be charged separately.

No, the doctor sees adult patients only.

• experience — 25 years
• Dr. Abdulla Mohammed Al Mehrezi is a distinguished Hematology & Oncology Consultant with 25 of expertise in diagnosing and managing complex hematological and oncological conditions.
• Board-certified by both the American and Canadian Boards in Medical Oncology, Hematology, and Internal Medicine, Dr. Al Mehrezi has built a reputation for delivering exceptional patient care and leading multidisciplinary teams in high-pressure medical environments. His career spans prominent institutions, including private & governmental institution in Abu Dhabi.
• He has spearheaded initiatives that enhanced clinical efficiency and improved patient outcomes through advanced treatment protocols and collaborative care models in the past at governmental institution.
• Dr. Al Mehrezi is deeply committed to patient education, family counseling, and the integration of evidence-based practices into clinical settings. His dedication to excellence and his ability to manage complex cases, including bone marrow transplants, have solidified his standing as a trusted expert in the field.

• Awards & Achievements:

  • 2018: American Board Recertification in Hematology
  • 2017: American Board Recertification in Internal Medicine
  • 2010: American Board in Medical Oncology
  • 2010: Canadian Board in Medical Oncology
  • 2009: Canadian Board in Hematology
  • 2008: American Board in Hematology
  • 2008: Canadian Board in Internal Medicine
  • 2007: American Board in Internal Medicine
  • 2000: MB, BCH, LRCP&SI, BAO – Royal College of Surgeons in Ireland

• Expertise:

  • Advanced hematology and oncology patient care  
  • Bone marrow transplantation and stem cell therapies  
  • Multidisciplinary cancer care coordination  
  • Implementation of cutting-edge cancer treatment protocols  
  • Leadership in clinical and operational management  

• Membership:

  • Member of the American Society of Hematology (ASH)  
  • Member of the American Society of Clinical Oncology (ASCO)  
  • Member of the Emirates Medical Association